"Aclarubicin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.
| Descriptor ID |
D015250
|
| MeSH Number(s) |
D02.455.426.559.847.562.050.050 D04.615.562.050.050 D09.408.051.059.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aclarubicin".
Below are MeSH descriptors whose meaning is more specific than "Aclarubicin".
This graph shows the total number of publications written about "Aclarubicin" by people in this website by year, and whether "Aclarubicin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aclarubicin" by people in Profiles.
-
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients. Oncotarget. 2015 Oct 20; 6(32):33612-22.
-
Quantitation of the nucleophosmin/B23-translocation using imaging analysis. Cancer Lett. 1996 Feb 27; 100(1-2):191-7.
-
Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Apr; 6(2):187-90.